A detailed history of Stanley Druckenmiller (Duquesne Family Office LLC) transactions in Insmed Inc stock. As of the latest transaction made, Duquesne Family Office LLC holds 20,000 shares of INSM stock, worth $1.43 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
20,000
Holding current value
$1.43 Million
% of portfolio
0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $440,000 - $1.39 Million
20,000 New
20,000 $1.34 Million
Q3 2020

Nov 16, 2020

SELL
$26.0 - $34.5 $31.9 Million - $42.3 Million
-1,227,400 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$14.11 - $29.42 $17.3 Million - $36.1 Million
1,227,400 New
1,227,400 $33.8 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.71B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track Stanley Druckenmiller's Portfolio

Track Stanley Druckenmiller Portfolio

Follow Stanley Druckenmiller (Duquesne Family Office LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duquesne Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Duquesne Family Office LLC and Stanley Druckenmiller with notifications on news.